Bibliography

ONE HAND CLAPPING FOR SCIENCE

 

 

1.  Buchert, R., Thomasius, R., Wilke, F., Peterson, K., Nebeling, B., Obrocki, J., Schulze, O., Schmidt, U., Clausen, A voxel-based PET investigation of the long-term effects of ³Ecstasy² consumption on brain serotonin transporters. Am. J. Psychiat. 161: 1181-1189 (2004).

 

2.  Budney, A.J., Hughes, J.R., Moore, B.A., Vandrey, R., Review of the validity and significance of cannabis withdrawal syndrome.  Am. J. Psychiat. 161: 1967-1977 (2004).

 

3.  Carroll, C.B., Bain, P.G., Teare, L., Liu, X., Joint, C., Wroath, C., Parkin, S.G., Fox, P., Wright, D., Hobart, J., Zajicek, J.P., Cannabis for dyskinesia in Parkinson disease.  Neurol. 63: 1245-1250 (2004).

 

4.  Dackis, C.A., Kampman, K.M., Lynch, K.G., Pettinati, H.M., and O¹Brien, C.P., A double-blind, placebo-controlled trial of Modafinil for cocaine dependence.  Neuropsychopharmacol. 30: 205-211 (2005).

 

5.  Hollander, E., Pallanti, S., Allen, A., Sood, E., Rossi, N.B., Does sustained-released lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?  Am. J. Psychiat. 162: 137-145 (2005).

 

6.  Nutt, D., Cannabis antagonists:  a new era of social psychopharmacology?  J. Psychopharm. 19: 3-4 (2005).

 

7.  O¹Malley, S.S., Rounsaville, B.J., Farren, C., Namkoong, K., Wu, R., Robinson, J., O¹Connor, P.G., Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs. specialty care.  Arch. Intern. Med.  163: 1695-1704 (2003).

 

8.  Pertwee, R.G., Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.  Life Sci. 76: 1307-1324 (2005).

 

9.  Peters, K.D., Wood, R.I., Androgen dependence in hamsters:  Overdose, tolerance, and potential opioidergic mechanisms.  Neurosci. 130: 971-981 (2004).

 

10. Reuter, J., Raedler, T., Rose, M., Hand, I., Glœscher, J., Büche, C., Pathological gambling is linked to reduced activation of the mesolimbic reward system.  Nature Neurosci. 8:147-148 (2005).

 

 

 

 

 

 

 

For further information, please write or call:

University of Texas
Addiction Science Research and Education Center
The College of Pharmacy
1 University Station A1915, PHR 5.210
Austin TX 78712-0125
512.471.5198
fax 512.471.5198
Carlton Erickson, Director

11 April 2005